Rb Energy Inc (RBEIF) 0.0050 $RBEIF RB Energy Reports

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Rb Energy Inc (RBEIF) 0.0050 $RBEIF

RB Energy Reports Appointment of Receiver
Marketwired - Fri May 08, 2:39PM CDT
RB Energy Inc. (the "Company" or "RB Energy" reports that the Court has appointed a receiver and provides a final update on the status of the Court approved sale and investor solicitation process (the "SISP" and proceedings under the Companies' Creditors Arrangement Act ("CCAA".

RB Energy Provides an Update on the Status of Sale and Investor Solicitation Process
Marketwired - Mon Apr 06, 7:01AM CDT
RB Energy Inc. (the "Company" or "RB Energy" provides an update on the status of the Court approved sale and investor solicitation process (the "SISP". No "Qualified Offers" were received by the SISP deadline of March 27, 2015 (the "Offer Deadline". The Company has developed an alternative course of action to attempt to obtain value for its stakeholders prior to the maturity date of the US $13 million "Debtor-in-Possession" loan ("DIP Loan" of April 15, 2015.

RB Energy Provides an Update on Sale and Investment Solicitation Process
Marketwired - Thu Feb 05, 7:04AM CST
RB Energy Inc. (the "Company" or RB Energy" would like to provide an update on the Court approved sale and investor solicitation process (the "SISP".

RB Energy Reports Q3 2014 Results
Marketwired - Fri Nov 14, 6:01PM CST
RB Energy Inc. (the "Company" or "RBI" or RB Energy" (TSX: RBI)(OTCQX: RBEIF) reports financial and operating results for the three and nine months ended September 30, 2014. The consolidated financial statements together with Management's Discussion and Analysis will be available on the Company's web site (www.rb-e.com) and on SEDAR (www.sedar.com).
RBI.TO: ()

General Agent Cooperation Framework Agreement Signed Between ElanOre Resources and Fancy Mining Industry Co., Ltd. for Spodumene Concentrate
Filing Services Canada XHTML - Thu Nov 06, 6:04AM CST

JOR.VN: 0.050 (unch)

Predictably: Lithium Prices Plateau, Mining Juniors Falter and Investors Lose! - TRU Says Lithium Space Needs a Major Recharge!
PR Newswire - Mon Nov 03, 5:18AM CST
Lithium engineering consultants TRU says that lithium prices in 2014 have performed close to our prediction of five years ago. TRU president Edward Anderson says, "Latest Chile monthly export data shows lithium carbonate prices lower by 2.3% for the year at US$4,600 per t. This level is the new long term norm." (See TRU lithium price forecast chart 2009-2015 on our website). Prices are kept in check by new supply from pipeline projects and plant expansions by the big-three low-cost lithium producers - SQM, FMC and Rockwood Lithium. Albemarle Corporation (who recently acquired Rockwood) could add further to supply as it is now in a good strategic position to extract lithium as a by-product of its established brine-based bromine operation in Arkansas, USA.
ALB: 50.72 (+0.15)

TSX Delisting Review - RB Energy Inc. (Symbol: RBI)
CNW Group - Thu Oct 23, 7:30AM CDT
DELISTING REVIEW RB Energy Inc. (the "Company" - Further to TSX Bulletin 2014-1101 dated October 14, 2014, TSX has determined to delist the common shares (Symbol: RBI) of the Company at the close of business on November 24, 2014 for failure to meet the continued listing requirements of TSX. The common shares will remain suspended from trading.
RBI.TO: (), X.TO: 48.95 (-0.53)

TSX to De-List RB Energy Shares as a Result of the Company Having Filed for Creditor Protection
Marketwired - Wed Oct 22, 6:38PM CDT
RB Energy Inc. (the "Company" or "RBI" (TSX: RBI)(OTCQX: RBEIF) has been advised by the Toronto Stock Exchange (the "TSX" that it will de-list the Company's common shares effective at the close of business on November 24, 2014 for failure to meet the continued listing requirements of the TSX. The Company's common shares will remain suspended from trading until that time.
RBI.TO: ()

RB Energy Receives Initial Order Under CCAA
Marketwired - Wed Oct 15, 7:36PM CDT
RB Energy Inc. (the "Company" or "RBI" (TSX: RBI)(OTCQX: RBEIF) announces that the Quebec Superior Court has issued an Amended and Restated Initial Order in respect of the Company and certain of its subsidiaries under the Companies' Creditors Arrangement Act (the "CCAA". The Company is now under the protection of the Court.
RBI.TO: ()

RB Energy Receives Temporary Order Under CCAA
Marketwired - Tue Oct 14, 7:54PM CDT
RB Energy Inc. (the "Company" or "RBI" (TSX: RBI)(OTCQX: RBEIF) announces that the hearing of the Motion for an Order under the CCAA will resume tomorrow, October 15, 2014, in the Quebec Superior Court. In the interim, the Quebec Superior Court has issued a Limited Initial Order under the Companies' Creditors Arrangement Act (the "CCAA" in respect of the Company and certain of its subsidiaries. The Limited Initial Order provides for a stay of all proceedings until 11:59 p.m. on October 15, 2014 and appoints KPMG LLP as monitor of the business and financial affairs of the Company. The Company is under the protection of the Court during the period of the Limited Initial Order.
RBI.TO: ()

IIROC Trading Halt - RBI
CNW Group - Tue Oct 14, 6:55AM CDT
The following issues have been halted by IIROC:
RBI.TO: ()

RB Energy to File for Creditor Protection
Marketwired - Mon Oct 13, 7:17PM CDT
RB Energy Inc. (the "Company" or "RBI" (TSX: RBI) (OTCQX: RBEIF) announces that, in light of the Company's current financial situation, to facilitate an orderly restructuring of its business and operations, the Board of Directors of the Company has approved a filing on Tuesday, October 14, 2014, for an Initial Order to commence proceedings under the Companies' Creditors Arrangement Act (the "CCAA" from the Quebec Superior Court. The terms and conditions of the restructuring have not yet been determined.
RBI.TO: ()

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 15

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 31

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

BioSyent Inc. to Announce Q3 Financial Results This Month

Updated Category News Views 189

BioSyent Inc. to Announce Q3 Financial Results BioSyent Inc., a prominent player in the specialty pharmaceutical industry, is preparing to release its financial results for the third quarter and year-to-date period. This important announcement is scheduled for November 20, prior to the market opening. The report will cover the company's performance for the three and nine...

Continue Reading
Dr. Ryan Egeland Joins Solventum as Chief Medical Officer

Updated Category News Views 381

Solventum Welcomes Dr. Ryan Egeland as New CMO Solventum, a pioneering healthcare company, recently announced the appointment of Dr. Ryan Egeland, MD, as their Chief Medical Officer. In this significant role, Dr. Egeland will lead the Global Medical and Clinical Affairs team, amplifying clinician and patient voices within the organization. Fostering Collaboration and...

Continue Reading
MiningToken Revolutionizes Cryptocurrency With AI Power

Updated Category News Views 186

Introducing MiningToken's Innovative AI Cloud Mining Service Bitcoin and Ethereum are experiencing remarkable market dynamics as Bitcoin persists in a bullish trend and Ethereum has gained notable ground recently. As global interest in cryptocurrencies grows, effective mining strategies are crucial for profitability. Amidst rising operational costs, many individuals seek...

Continue Reading
Saluda Medical's EVA™ Sensing Technology Approved in Europe

Updated Category News Views 111

Saluda Medical Achieves Regulatory Milestone with EVA™ Technology Saluda Medical, Inc. (ASX:SLD) has made significant strides in the medical device industry by achieving CE certification for its next-generation EVA™ Sensing Technology. This advancement not only marks a major endorsement in Europe but also is recognized in Australia. Following FDA approval in December...

Continue Reading
ReadPartner Inc. Unveils Revolutionary AI Tool to Combat Misinformation

Updated Category News Views 291

ReadPartner Inc. Launches AI Feature to Tackle Misinformation ReadPartner Inc., a leader in AI-driven media intelligence solutions, is excited to announce the upcoming launch of a groundbreaking digital security feature named ProfileScreen. This innovative tool aims to address the pressing issue of misinformation that plagues social media platforms. The ProfileScreen...

Continue Reading